Please use this identifier to cite or link to this item:
Title: Mepolizumab and exacerbations of refractory eosinophilic asthma.
Authors: Haldar, P
Brightling, CE
Hargadon, B
Gupta, S
Monteiro, W
Sousa, A
Marshall, RP
Bradding, P
Green, RH
Wardlaw, AJ
Pavord, ID
First Published: 5-Mar-2009
Citation: N ENGL J MED, 2009, 360 (10), pp. 973-984
Abstract: Exacerbations of asthma are associated with substantial morbidity and mortality and with considerable use of health care resources. Preventing exacerbations remains an important goal of therapy. There is evidence that eosinophilic inflammation of the airway is associated with the risk of exacerbations.
DOI Link: 10.1056/NEJMoa0808991
eISSN: 1533-4406
Type: Journal Article
Appears in Collections:Published Articles, Dept. of Infection, Immunity and Inflammation

Files in This Item:
There are no files associated with this item.

Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.